# A Phase 1b Study of ZN-c3 in Chinese Subjects

> **NCT04972422** · PHASE1 · UNKNOWN · sponsor: **Zentera Therapeutics HK Limited** · enrollment: 38 (estimated)

## Conditions studied

- Solid Tumors

## Interventions

- **DRUG:** ZN-c3

## Key facts

- **NCT ID:** NCT04972422
- **Lead sponsor:** Zentera Therapeutics HK Limited
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2021-07-15
- **Primary completion:** 2022-06-30
- **Final completion:** 2023-06-30
- **Target enrollment:** 38 (ESTIMATED)
- **Last updated:** 2021-09-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04972422

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04972422, "A Phase 1b Study of ZN-c3 in Chinese Subjects". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT04972422. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*